Cargando…

Neuropsychiatric Disorders in Chronic Kidney Disease

Neuropsychiatric conditions including depression, anxiety disorders, and cognitive impairment are prevalent in patients with chronic kidney disease (CKD). These conditions often make worse the quality of life and also lead to longer hospitalizations and higher mortality. Over the past decades, some...

Descripción completa

Detalles Bibliográficos
Autores principales: Simões e Silva, Ana Cristina, Miranda, Aline Silva, Rocha, Natalia Pessoa, Teixeira, Antônio Lúcio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707423/
https://www.ncbi.nlm.nih.gov/pubmed/31474869
http://dx.doi.org/10.3389/fphar.2019.00932
_version_ 1783445857902788608
author Simões e Silva, Ana Cristina
Miranda, Aline Silva
Rocha, Natalia Pessoa
Teixeira, Antônio Lúcio
author_facet Simões e Silva, Ana Cristina
Miranda, Aline Silva
Rocha, Natalia Pessoa
Teixeira, Antônio Lúcio
author_sort Simões e Silva, Ana Cristina
collection PubMed
description Neuropsychiatric conditions including depression, anxiety disorders, and cognitive impairment are prevalent in patients with chronic kidney disease (CKD). These conditions often make worse the quality of life and also lead to longer hospitalizations and higher mortality. Over the past decades, some hypotheses have tried to explain the connection between CKD and neuropsychiatric disorders. The most common hypothesis is based on the occurrence of cerebrovascular disease and accumulated uremic toxins in adult patients with CKD. However, the lack of a direct association between known vascular risk factors (e.g., diabetes and hypertension) with CKD-related cognitive deficits suggests that other mechanisms may also play a role in the pathophysiology shared by renal and neuropsychiatric diseases. This hypothesis is corroborated by the occurrence of neuropsychiatric comorbidities in pediatric patients with CKD preceding vascular damage, and the inconsistent findings on neuroprotective effects of antihypertensives. The aim of this narrative review was to summarize clinical evidence and potential mechanisms that links CKD and brain disorders, specifically in regard to cognitive impairment, anxiety, and depression.
format Online
Article
Text
id pubmed-6707423
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67074232019-08-30 Neuropsychiatric Disorders in Chronic Kidney Disease Simões e Silva, Ana Cristina Miranda, Aline Silva Rocha, Natalia Pessoa Teixeira, Antônio Lúcio Front Pharmacol Pharmacology Neuropsychiatric conditions including depression, anxiety disorders, and cognitive impairment are prevalent in patients with chronic kidney disease (CKD). These conditions often make worse the quality of life and also lead to longer hospitalizations and higher mortality. Over the past decades, some hypotheses have tried to explain the connection between CKD and neuropsychiatric disorders. The most common hypothesis is based on the occurrence of cerebrovascular disease and accumulated uremic toxins in adult patients with CKD. However, the lack of a direct association between known vascular risk factors (e.g., diabetes and hypertension) with CKD-related cognitive deficits suggests that other mechanisms may also play a role in the pathophysiology shared by renal and neuropsychiatric diseases. This hypothesis is corroborated by the occurrence of neuropsychiatric comorbidities in pediatric patients with CKD preceding vascular damage, and the inconsistent findings on neuroprotective effects of antihypertensives. The aim of this narrative review was to summarize clinical evidence and potential mechanisms that links CKD and brain disorders, specifically in regard to cognitive impairment, anxiety, and depression. Frontiers Media S.A. 2019-08-16 /pmc/articles/PMC6707423/ /pubmed/31474869 http://dx.doi.org/10.3389/fphar.2019.00932 Text en Copyright © 2019 Simões e Silva, Miranda, Rocha and Teixeira http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Simões e Silva, Ana Cristina
Miranda, Aline Silva
Rocha, Natalia Pessoa
Teixeira, Antônio Lúcio
Neuropsychiatric Disorders in Chronic Kidney Disease
title Neuropsychiatric Disorders in Chronic Kidney Disease
title_full Neuropsychiatric Disorders in Chronic Kidney Disease
title_fullStr Neuropsychiatric Disorders in Chronic Kidney Disease
title_full_unstemmed Neuropsychiatric Disorders in Chronic Kidney Disease
title_short Neuropsychiatric Disorders in Chronic Kidney Disease
title_sort neuropsychiatric disorders in chronic kidney disease
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707423/
https://www.ncbi.nlm.nih.gov/pubmed/31474869
http://dx.doi.org/10.3389/fphar.2019.00932
work_keys_str_mv AT simoesesilvaanacristina neuropsychiatricdisordersinchronickidneydisease
AT mirandaalinesilva neuropsychiatricdisordersinchronickidneydisease
AT rochanataliapessoa neuropsychiatricdisordersinchronickidneydisease
AT teixeiraantoniolucio neuropsychiatricdisordersinchronickidneydisease